Skip Navigation


Brain Advance Access originally published online on May 11, 2005
Brain 2005 128(8):1790-1801; doi:10.1093/brain/awh539
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
128/8/1790    most recent
awh539v2
awh539v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kim, E. J.
Right arrow Articles by Na, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, E. J.
Right arrow Articles by Na, D. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2005). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients

E. J. Kim1, S. S. Cho3, Y. Jeong6, K. C. Park4, S. J. Kang1, E. Kang5, S. E. Kim3, K. H. Lee2 and D. L. Na1

1 Department of Neurology, 2 Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 3 Department of Nuclear Medicine, Seoul National University College of Medicine, 4 Department of Neurology, College of Medicine, Kyung Hee University, Seoul, 5 Department of Psychology, Kangwon National University, Chuncheon, Korea and 6 Department of Neurology, University of Florida and Veterans Affairs Medical Center, Gainesville, FL, USA

Correspondence to: Duk L. Na, MD, Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-dong, Kangnam-gu, Seoul 135-710, Korea E-mail: dukna{at}smc.samsung.co.kr

The aims of this cross-sectional study were (i) to compare the overall glucose metabolism between early onset and late onset Alzheimer's disease in a large sample of patients; and (ii) to investigate the pattern of glucose metabolism as a function of dementia severity in early onset versus late onset Alzheimer's disease, using a statistical parametric mapping (SPM) analysis. Subjects consisted of four groups: 74 patients with early onset Alzheimer's disease, 46 patients with late onset of the disease, and two control groups age matched to each patient group. All the subjects underwent 2-[18F]fluoro-2-deoxy-D-glucose (FDG)-PET under the same scanning conditions. Severity of dementia was rated with the Clincial Dementia Rating (CDR). Voxel-based SPM99 was used for statistical analyses. Overall glucose hypometabolism of early onset Alzheimer's disease patients was much greater in magnitude and extent than that of late onset patients, though both groups were similar in dementia severity: the early onset group showed more severe hypometabolism in parietal, frontal and subcortical (basal ganglia and thalamus) areas. When the decline of glucose metabolism was compared as a function of CDR stage, the slope was steeper in early onset than in late onset Alzheimer's disease. The rapid decline occurred at CDR 0.5–1 in the early onset group, whereas similar changes occurred at CDR 2–3 in the late onset group. The greater hypometabolism in early onset than in late onset patients is required to reach the same severity of dementia, probably reflecting greater functional reserve in younger than in older subjects. Alternatively, the metabolic decline curve suggests that the early onset patients may take a more rapid course in the reduction of glucose metabolism than the late onset patients.

Key Words: Alzheimer's disease; early onset; late onset; PET; statistical parametric mapping

Abbreviations: CDR = Clinical Dementia Rating; COWAT = Controlled Oral Word Association Test; FDG = 2-[18F]fluoro-2-deoxy-D-glucose; MMSE = Mini-Mental State Examination; RCFT = Rey–Osterrieth Complex Figure test; ROI = region of interest; SNSB = Seoul Neuropsychological Screening Battery; SPM = statistical parametric mapping

Received November 19, 2004. Revised February 15, 2005. Accepted April 8, 2005.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
NeurologyHome page
E. J. Kim, B. H. Lee, S. W. Seo, S. Y. Moon, D. S. Jung, K. H. Park, K. M. Heilman, and D. L. Na
Attentional distractibility by optokinetic stimulation in Alzheimer disease
Neurology, September 11, 2007; 69(11): 1105 - 1112.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. Won Seo, B. Hwa Lee, E.-J. Kim, J. Chin, Y. Sun Cho, U. Yoon, and D. L. Na
Clinical Significance of Microbleeds in Subcortical Vascular Dementia
Stroke, June 1, 2007; 38(6): 1949 - 1951.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
H. Matsuda, S. Mizumura, T. Nagao, T. Ota, T. Iizuka, K. Nemoto, N. Takemura, H. Arai, and A. Homma
Automated Discrimination Between Very Early Alzheimer Disease and Controls Using an Easy Z-Score Imaging System for Multicenter Brain Perfusion Single-Photon Emission Tomography
AJNR Am. J. Neuroradiol., April 1, 2007; 28(4): 731 - 736.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. R. Hodges
Alzheimer's centennial legacy: origins, landmarks and the current status of knowledge concerning cognitive aspects.
Brain, November 1, 2006; 129(Pt 11): 2811 - 2822.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. T. Du, G. H. Jahng, S. Hayasaka, J. H. Kramer, H. J. Rosen, M. L. Gorno-Tempini, K. P. Rankin, B. L. Miller, M. W. Weiner, and N. Schuff
Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI.
Neurology, October 10, 2006; 67(7): 1215 - 1220.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.